Dear PES members, It is an honor and privilege to start my term as PES President. I want to thank…
Read MoreMore Articles
Brief Therapeutic Update from PES Drugs and Therapeutics Committee Jardiance® (empagliflozin) and Synjardy® (empagliflozin and metformin hydrochlorothiazide) Jardiance® (empagliflozin) and Synjardy® (empagliflozin and metformin hydrochlorothiazide) were approved by the…
Read More
New Meds and Tech from PES Drugs and Therapeutics committee Palovarotene (SohonosTM – Ipsen Pharmaceuticals Inc.) By: Ambika Ashraf, MD and Anna Ryabets-Lienhard, DO Update: 9/10/2023 On August…
Read More
Dear PES members and friends, Together with the Board of Directors, I have just been scoping out the venue for next year’s meeting in Chicago and couldn’t be more excited…
Read More
Historical Tidbit: Paracelsus (1493-1541). A Man for All Seasons Submitted by Alan D. Rogol, M.D., Ph.D. Paracelsus, born Philippus Aureolus Theophrastue Bombastus von Hoenheim was a Swiss chemist and physician…
Read More
Ana Menendez, MD My name is Ana Menendez and I am a third-year pediatric endocrinology fellow at the University of Connecticut, Connecticut Children’s Medical Center. I obtained my medical degree…
Read More
Dear PES members and friends, Activity is ramping up — ‘back-to-school’ advertisements are out, reminding us of the general rush to get down to business as the summer ends. With…
Read More
Historical Tidbit: Jan Wolff (b. April 25, 1925) and Israel L. Chaikoff (b. July 2, 1902)—the Wolff-Chaikoff Effect Submitted by Alan D. Rogol, M.D., Ph.D. Wolff and Chaikoff discovered that…
Read More
Adriana Rodríguez González, MD I am currently a 3rd year Pediatric Endocrinology Fellow at UPMC Children’s Hospital in Pittsburgh, PA. I received my undergraduate degree at the University of Puerto Rico…
Read More
Dear PES members and friends, Midsummer greetings to all – these quieter days are flying by, as they tend to do, so hopefully you are getting some relaxation and sunshine,…
Read More
Brief Therapeutic Update from PES Drugs and Therapeutics Committee iLet ® Bionic Pancreas On May 19, 2023, the U.S. Food and Drug Administration approved the Beta Bionics iLet ACE…
Read More